Pemetrexed(P) in Third and Fourth Line Chemotherapy for Advanced Non-Small Cell Lung Cancer (Non-Squamous)-aNSCLCns

被引：0
|
作者：
Grigorescu, Alexandru Calin [1 ]
Ilie, Dan [2 ]
机构：
[1] Inst Oncol Bucharest, Med Oncol Li, Bucharest, Romania
[2] Inst Oncol Bucharest, Bucharest, Romania
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 01期
关键词：
Advanced Nonsmall-Cell lung Cancer; chemotherapy; Third line chemotherapy;
D O I：
10.1016/j.jtho.2016.11.1276
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.03a-066
引用
收藏
页码：S929 / S929
页数：1
相关论文
共 50 条
  • [31] Atezolizumab in non-squamous non-small cell lung cancer
    Akamine, Takaki
    Toyokawa, Gouji
    Tagawa, Tetsuzo
    Seto, Takashi
    JOURNAL OF THORACIC DISEASE, 2018, 10 : S3155 - S3159
  • [32] A Randomized Phase II Study of Maintenance Bevacizumab, Pemetrexed or Bevacizumab Plus Pemetrexed for Advanced Non-squamous Non-small Cell Lung Cancer
    Yoshida, Hironori
    Kim, Young Hak
    Sakamori, Yuichi
    Nagai, Hiroki
    Ozasa, Hiroaki
    Kaneda, Toshihiko
    Yoshioka, Hiroshige
    Nakagawa, Hiroaki
    Tomii, Keisuke
    Okada, Asuka
    Yoshimura, Kenichi
    Hirabayashi, Masataka
    Hirai, Toyohiro
    ANTICANCER RESEARCH, 2020, 40 (05) : 2981 - 2987
  • [33] TOLERANCE AND EFFICACY OF PEMETREXED-CISPLATIN FOR ADVANCED NON-SQUAMOUS NON-SMALL CELL LUNG CANCER A GALICIAN LUNG CANCER GROUP STUDY
    Senin, Clara
    Campos, Begona
    Jose Villanueva, Maria
    Firvida, J. L.
    Baron, Francisco
    Amenedo, Margarita
    Afonso, Javier
    Lazaro, Martin
    Varela, S.
    Grande, C.
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1277 - S1277
  • [34] Efficacy and Safety of Pemetrexed-Cisplatin for Advanced Non-Squamous Non-Small Cell Lung Cancer - a Galician Lung Cancer Group Study
    Senin, C.
    Varela, S.
    Huidobro, G.
    Firvida, J. L.
    Baron, F.
    Amenedo, M.
    Afonso, F. J.
    Lazaro, M.
    Campos, B.
    Casal, J.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S624 - S624
  • [35] Clinical efficacy of bevacizumab combined with chemotherapy in the treatment of advanced non-squamous non-small cell lung cancer
    Liu, Yuhua
    Mao, Aihong
    Ma, Qin
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 12 (07): : 9049 - 9057
  • [36] Pemetrexed as the first-line therapy for Chinese patients with advanced non-squamous non-small-cell lung cancer
    Xu, Bei
    Liu, Peng
    Yin, Yongmei
    Liu, Ping
    Shu, Yongqian
    BIOMEDICINE & PHARMACOTHERAPY, 2013, 67 (08) : 763 - 769
  • [37] Smoking History as a Predictor of Pemetrexed Monotherapy in Patients with Non-Squamous Non-Small Cell Lung Cancer
    Igawa, Satoshi
    Sasaki, Jiichiro
    Otani, Sakiko
    Shirasawa, Masayuki
    Niwa, Hideyuki
    Kusuhara, Seiichiro
    Harada, Shinya
    Kubota, Masaru
    Katagiri, Masato
    Masuda, Noriyuki
    ONCOLOGY, 2016, 91 (01) : 41 - 47
  • [38] PHARMACOGENETIC STUDY OF JAPANESE PATIENTS WITH ADVANCED NON-SQUAMOUS NON-SMALL CELL LUNG CANCER TREATED WITH PEMETREXED PLUS CISPLATIN
    Imai, Hisao
    Takahashi, Toshiaki
    Serizawa, Masakuni
    Mori, Keita
    Ono, Akira
    Akamatsu, Hiroaki
    Taira, Tetsuhiko
    Nakamura, Yukiko
    Kenmotsu, Hirotsugu
    Naito, Tateaki
    Murakami, Haruyasu
    Koh, Yasuhiro
    Endo, Masahiro
    Nakajima, Takashi
    Yamamoto, Nobuyuki
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1077 - S1077
  • [39] Clinical features of patients with advanced non-squamous non-small cell lung cancer treated with long-term pemetrexed
    Hirai, Kenichiro
    Yokouchi, Hiroshi
    Azuma, Keisuke
    Minemura, Hiroyuki
    Sekine, Satoko
    Kanazawa, Kenya
    Tanino, Yoshinori
    Munakata, Mitsuru
    ANNALS OF ONCOLOGY, 2015, 26 : 123 - 123
  • [40] Phase I Study of Carboplatin Combined with Pemetrexed for Elderly Patients with Advanced Non-squamous Non-small Cell Lung Cancer
    Takeoka, Hiroaki
    Yamada, Kazuhiko
    Azuma, Koichi
    Zaizen, Yoshiaki
    Yamashita, Fumie
    Yoshida, Tsukasa
    Naito, Yoshiko
    Okayama, Yusuke
    Miyamoto, Maki
    Hoshino, Tomoaki
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2014, 44 (05) : 472 - 478
12345